Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . September 23rd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis B Therapy - Regimens altering lamivudine and interferon yield similar results in children
Proficiency Testing - Although hepatitis C assays are good, there is still room for improvement
Hepatitis B Therapy - New inhibitors show promise for eradicating hepatitis drug-resistant mutants
Hepatitis B Vaccine - Hip or thigh yield comparable vaccine protection in immunized infants
Kidney Failure - Hepatitis B vaccine best administered to children before end-stage liver disease
Appointments - Bill Forbes joins tapped as VP
Appointments - Triangle Pharmaceuticals names Daniel G. Welch chairman and CEO
Cancer Therapy - Method using clots to block arteries effective, safe for small liver tumors
Encephalitis - Maxygen receives $2.4 million grant to develop cross protective vaccines
Fatigue - Weight controlling protein may be source of fatigue in chronic hepatitis C
Finance - AERx systems maker reports net loss for 6 months of 2002: $0.62 per share
Finance - Nabi product sales growth drives positive cash flow
Finance - Revenues increase 18.2% for infectious disease detection and monitoring company
Hepatitis C - Ribapharm files patent infringement lawsuit in Germany against Hoffmann-La Roche
Infectious Disease - Zadaxin produces sustained responses in hard-to-treat hepatitis B patients
Interferon - Treatment results often poor in those with hepatitis C virus genotype 4
Patents - New patent covers antiviral compounds
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
